For the BLUECHOICE HEALTHPLAN OF SOUTH CAROLINA
Managed Medicaid Program

Recent Updates

PW_B126827
Publish Date 12/12/2018  
 
New  
CG-LAB-14 Respiratory Viral Panel Testing in the Outpatient Setting
CG-MED-78 Anesthesia Services for Interventional Pain Management Procedures
CG-SURG-91 Minimally Invasive Ablative Procedures for Epilepsy
 
Revised  
CG-BEH-01 Screening and Assessment for Autism Spectrum Disorders and Rett Syndrome
CG-DRUG-45 Octreotide acetate (Sandostatin®; Sandostatin® LAR Depot)
CG-DRUG-62 Fulvestrant (FASLODEX®)
CG-DRUG-63 Levoleucovorin Products
CG-DRUG-65 Tumor Necrosis Factor Antagonists
CG-DRUG-77 Radium Ra 223 Dichloride (Xofigo®)
CG-DRUG-78 Antihemophilic Factors and Clotting Factors
CG-DRUG-107 Pharmacotherapy for Hereditary Angioedema
CG-GENE-01 Janus Kinase 2 (JAK2)V617F and JAK2 exon 12 Gene Mutation Assays
CG-GENE-03 BRAF Mutation Analysis
CG-MED-21 Anesthesia Services and Moderate (“Conscious”) Sedation
CG-MED-26 Neonatal Levels of Care
CG-REHAB-07 Skilled Nursing and Skilled Rehabilitation Services (Outpatient)
CG-SURG-27 Sex Reassignment Surgery
CG-SURG-60 Cervical Total Disc Arthroplasty
CG-THER-RAD-03 Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy
 
Archived  
CG-DRUG-31 Oncology Drug Treatment Regimens for Adults
CG-MED-60 Monitored Anesthesia Care and General Anesthesia for Cataract Surgery

BlueChoice HealthPlan is an independent licensee of the Blue Cross and Blue Shield Association.

Medicaid managed care administered by Amerigroup Partnership Plan, LLC, an independent company.